The most used fibrinolytics were tissue plasminogen activator (tPA) 2, 5, 9, 11, 16, 20 and urokinase. 1, 3, 6, 7, 17 Streptokinase was used in only 2 studies. 14, 19 The type of fibrinolytic used was ...

Direct thrombin inhibitors: 44% Fibrinolytics: 31% “There was heterogeneity in reported reversal practice for different antithrombotics in specific scenarios and between continents,” researchers ...

The presence of effusion leads to a prolonged length of stay (LOS), escalation of care, morbidity and increased healthcare resources utilisation. 6–10 Management of the effusion is controversial. 6 7 ...

In Myocardial Infarction (MI) patients care process, the time from the onset of the symptom to the time they receive the reperfusion strategy to prevent the myocardium loss is important. An ...

Introduction Patients with life-limiting illnesses are at increased risk of mucosal bleeding. Usual management includes anticipatory planning and sedation, alongside anti-fibrinolytics, despite a lack ...

A pharmacoinvasive strategy is another approach in the management of patients with ST-segment–elevation myocardial infarction (STEMI) when PPCI is not an option. With a pharmacoinvasive strategy, ...

The British Thoracic Society last released a recommendation on the management of pleural infections in 2010, before the publication of the MIST2 trial. 3 In 2015, a consensus statement by the European ...

There are three general categories of drugs that are commonly used to prevent or treat blood clots (thrombosis): anticoagulants, fibrinolytics, and antiplatelet medications. Some of these (Pradaxa, ...

Introduction The optimal management of pleural infection is uncertain. Randomised controlled trials have demonstrated the efficacy of intrapleural fibrinolytics, but uptake into local guidelines has ...

Pause (1 gm) 1gm - 10 Tablets (Tranexamic Acid) drug information. Find its price or cost, dose, when to use, how to use, side effects, adverse effects, substitutes . It is manufactured by Emcure ...